Back to mobile site
Get it on Google Play

Aethlon Medical advances to final trial cohort after safety review

March 24, 2026 8:01 AM EDT Send to a Friend
Aethlon Medical, Inc. (NASDAQ: AEMD) announced that an independent Data Safety Monitoring Board has approved advancement to the third and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login